Is BDNF biological link between depression and type 2 diabetes mellitus?

Medical Hypotheses

Volumn 79, Issue 2, 2012, Pages 255-258

  Wang, Jikun ^a   Zhao, Xudong ^a   He, Ming ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; INSULIN;

ALZHEIMER DISEASE; ARTICLE; CENTRAL NERVOUS SYSTEM; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; HYPERGLYCEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN RESISTANCE; MENTAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; RISK FACTOR; STRESS; SYMPTOM;

BIOLOGICAL MARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CAUSALITY; COMORBIDITY; DEPRESSION; DIABETES MELLITUS, TYPE 2; HUMANS; MODELS, BIOLOGICAL; PREVALENCE; RISK FACTORS;

EID: 84863318618     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.05.002     Document Type: Article

References (53)

1. Chaldakov G.N., Fiore M., Tonchev A.B., et al. Homo obesus: a metabotrophin-deficient species. Pharmacology and nutrition insight. Curr Pharm Des 2007, 13:2176-2179.
2. Nofuji Y., Suwa M., Moriyama Y., et al. Decreased serum brain-derived neurotrophic factor in trained men. Neurosci Lett 2008, 437:29-32.
3. Gratacos M., Gonzalez J.R., Mercader J.M., et al. Brainderived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol Psychiatry 2007, 61:911-922.
4. Noble E.E., Billington C.J., Kotz C.M., et al. The lighter side of BDNF. Am J Physiol Regul Integr Comp Physiol 2011, 300:R1053-R1069.
5. Rasmussen P., Brassard P., Adser H., et al. Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Exp Physiol 2009, 94:1062-1069.
6. Sartorius A., Hellweg R., Litzke J., et al. Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats. Pharmacopsychiatry 2009, 42:270-276.
7. Karege F., Schwald M., Cisse M. Postnatal developmental profile of brainderived neurotrophic factor in rat brain and platelets. Neurosci Lett 2002, 328:261-264.
8. Sen S., Duman R., Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta analyses and implications. Biol Psychiatry 2008, 64:527-532.
9. Ferris L.T., Williams J.S., Shen C.L. The effect of acute exercise on serum brain-derived neurotrophic factor levels and cognitive function. Med Sci Sports Exerc 2007, 39:728-734.
10. Tang S.W., Chu E., Hui T., et al. Influence of exercise on serum brain-derived neurotrophic factor concentrations in healthy human subjects. Neurosci Lett 2008, 431:62-65.
11. Fujinami A., Ohta K., Obayashi H., Fukui M., Hasegawa G., Nakamura N., et al. Serum brain-derived neurotrophic factor in patients with type 2 diabetes mellitus: relationship to glucose metabolism and biomarkers of insulin resistance. Clin Biochem 2008, 41:812-817.
12. Krabbe K.S., Nielsen A.R., Krogh-Madsen R., Plomgaard P., Rasmussen P., Erikstrup C., et al. Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia 2007, 50:431-438.
13. Gervasoni N., Aubry J.M., Bondolfi G., Osiek C., Schwald M., Bertschy G., et al. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 2005, 51:234-238.
14. Knol M.J., Twisk J.W., Beekman A.T., Heine R.J., Snoek F.J., Pouwer F. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 2006, 49:837-845.
15. Bogner H.R., Morales K.H., Post E.P., Bruce M.L. Diabetes, depression and death: a randomized controlled trial of a depression treatment program for older adults based in primary care (PROSPECT). Diabetes Care 2007, 30:3005-3010.
16. Hou S.J., Yen F.C., Tsai S.I. Is dysfunction of the tissue plasminogen activator (tPA)-plasmin pathway a link between major depression and cardiovascular disease?. Med Hypotheses 2009, 72:166-168.
17. Knol M.J., Heerdink R., Egberts A.C., Geerlings M.I., Gorter K.J., Numans M.E., et al. Depressive symptoms in subjects with diagnosed and undiagnosed type 2 diabetes. Psychosom Med 2007, 69:300-305.
18. Golden S.H., Lazo M., Carnethon M., Bertoni A.G., Schreiner P.J., Diezz Roux A.V., et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA 2008, 299:2751-2759.
19. Engum A. The role of depression and anxiety in onset of diabetes in a large population-based study. J Psychosom Res 2007, 62:31-38.
20. Harris M.D. Psychosocial aspects of diabetes with an emphasis on depression. Curr Diabetes Rep 2003, 3:49-55.
21. Duncan B.B., Schmidt M.I., Pankow J.S., Ballantyne C.M., Couper D., Vigo A., et al. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2003, 52:1799-1805.
22. Okamura F., Tashiro A., Utumi A., Imai T., Tamura D., Sato Y., et al. Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. Metabolism 2000, 49:1255-1260.
23. Yamanaka M., Tsuchida A., Nakagawa T., Nonomura T., Ono-Kishino M., Suqaru E., et al. Brain-derived neurotrophic factor enhances glucose utilization in peripheral tissues of diabetic mice. Diabetes Obes Metab 2007, 9:59-64.
24. Arentoft A., Sweat V., Starr V., et al. Plasma BDNF is reduced among middle-aged and elderly women with impaired insulin function: evidence of a compensatory mechanism. Brain Cogn 2009, 71:147-152.
25. Yamanaka M., Itakura Y., Ono-Kishino M., et al. Intermittent administration of brain-derived neurotrophic factor (BDNF) Ameliorates glucose metabolism and prevents pancreatic exhaustion in diabetic mice. J Biosci Bioeng 2008, 105:395-402.
26. Yu Y., Wang Q., Huang X.F. Energy-restricted pair-feeding normalizes low levels of brain-derived neurotrophic factor/tyrosine kinase B mRNA expression in the hippocampus, but not ventromedical hypothalamic nucleus, in diet-induced obese mice. Neuroscience 2009, 160:295-306.
27. Rao A.A., Sridhar G.R., Srinivas B., et al. Bioinformatics analysis of functional protein sequences reveals a role for brain-derived neurotrophic factor in obesity and type 2 diabetes mellitus. Med Hypotheses 2008, 70:424-429.
28. Karczewska-Kupczewska M., Straczkowski M., Adamska A., et al. Decreased serum brain-derived neurotrophic factor concentration in young nonobese subjects with low insulin sensitivity. Clin Biochem 2011, 44:817-820.
29. Eikelis N., Esler M., Barton D., Dawood T., Wiesner G., Lambert G. Reduced brain leptin in patients with major depressive disorder and in suicide victims. Mol Psychiatry 2006, 11:800-801.
30. Berton O., Mc Clung C.A., Dileone R.J., Krishnan V., Renthal W., Russo S.J., et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 2006, 311:864-868.
31. Karege F., Bondolfi G., Gervasoni N., Schwald M., Aubry J.M., Bertschy G. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 2005, 57:1068-1072.
32. Yoshimura R., Mitoma M., Sugita A., Hori H., Okamoto T., Umene W., et al. Effects of paroxetine or milnacipran on brain-derived neurotrophic factor in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:1034-1037.
33. Kim Y.K., Lee H.P., Won S.D., Park E.Y., Lee H.Y., Lee B.H., et al. Low plasma BDNF is associated with suicidal behavior in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:78-85.
34. Piccinni A., Marazziti D., Catena M., Domenici L., Del Debbio A., Bianchi C., et al. Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1year of antidepressant treatments. J Affect Disord 2008, 105:279-283.
35. Shi Y., You J., Yuan Y., Zhang X., Li H., Hou G. Plasma BDNF and tPA are associated with late-onset geriatric depression. Psychiatry Clin Neurosci 2010, 64:249-254.
36. Zeman M., Jachymova M., Jirak R., Vecka M., Tvrzicka E., Stankova B., et al. Polymorphisms of genes for brain-derived neurotrophic factor, methylenetetrahydrofolate reductase, tyrosine hydroxylase, and endothelial nitric oxide synthase in depression and metabolic syndrome. Folia Biologica (Praha) 2010, 56:19-26.
37. Roos C., Lidfeldt J., Agardh C.D., Nyberg P., Nerbrand C., Samsioe G., et al. Insulin resistance and self-rated symptoms of depression in Swedish women with risk factors for diabetes: the women's health in the Lund area study. Metab Clin Exp 2007, 56:825-829.
38. Dunn A.L., Trivedi M.H., Kampert J.B., Clark C.G., Chambliss H.O. Exercise treatment for depression: efficiency and dose response. Am J Prev Med 2005, 28:1-8.
39. Huang A.M., Jen C.J., Chen H.F., Yu L., Kuo Y.M., Chen H.I. Compulsive exercise acutely upregulates rat hippocampal brain-derived neurotrophic factor. J Neural Transm 2006, 113:803-811.
40. Angelucci F., Brene' S., Mathé A.A. BDNF in schizophrenia, depression and corresponding animal models. Mol Psychiatry 2005, 10:345-352.
41. Mattson M.P., Maudsley S., Martin B. A neural signaling triumvirate that influences ageing and age-related disease: insulin/IGF-1 BDNF and serotonin. Ageing Res Rev 2004, 3:445-464.
42. Lustman P.J., Clouse R.E. Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complications 2005, 19:113-122.
43. Rasgon N., Jarvik L. Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis. J Gerontol: Med Sci 2004, 59A:178-183.
44. Mc Ewen B.S. Glucocorticoids, depression and mood disorders: structural remodeling in the brain. Metabolism 2005, 54(Suppl. 1):20-23.
45. Duman R.S. Depression: a case of neuronal life and death?. Biol Psychiatry 2004, 56:140-145.
46. Park H.R., Park M., Choi J., Park K.Y., Chung H.Y., Lee J. A high-fat diet impairs neurogenesis: involvement of lipid peroxidation and brain-derived neurotrophic factor. Neurosci Lett 2010, 482:235-239.
47. Lustman P.J., Clouse R.E., Nix B.D., et al. Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 2006, 63:521-529.
48. Mann J.J., Apter A., Bertolote J., Beautrais A., Currier D., Haas A., et al. Suicide prevention strategies: a systematic review. JAMA 2005, 294:2064-2074.
49. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006, 59:1116-1127.
50. Bus BA, Tendolkar I, Franke B, et al. Serum brain-derived neurotrophic factor determinants and relationship with depressive symptoms in a community population of middle-aged and elderly people. World J Biol Psychiatry 2011; Early Online: 1-9.
51. Laske C., Stransky E., Leyhe T., et al. Stage-dependent BDNF serum concentrations in Alzheimer's disease. J Neural Transm 2006, 113:1217-1224.
52. Brown L.C., Majumdar S.R., Johnson J.A. Type of antidepressant therapy and risk of Type 2 diabetes in people with depression. Diabetes Res Clin Pract 2008, 79:61-67.
53. Matrisciano F., Bonaccorso S., Ricciardi A., et al. Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6months treatment with sertraline, escitalopram, or venlafaxine. J Psychiatr Res 2009, 43:247-254.